Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas.


Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 29 07 2018
accepted: 22 02 2019
pubmed: 15 3 2019
medline: 4 6 2019
entrez: 15 3 2019
Statut: ppublish

Résumé

Identifying demographic, clinical, and geographical factors that contribute to disparities in the receipt of physician recommended chemotherapy in breast cancer patients. The Texas Cancer Registry was used to identify women aged ≥ 18 years with invasive breast cancer diagnosed from 2007 to 2011 who received a recommendation for chemotherapy. Multivariable logistic regression was performed to determine associations between demographic and clinical factors and the receipt of chemotherapy. Cox proportional regression was used to estimate the hazard ratio (HR) for overall survival. Spatial analysis was conducted using Poisson models for breast cancer mortality and receipt of chemotherapy. Age ≥ 65 years, residence in areas with > 20% poverty index, and early disease stage were associated with lack of receipt of chemotherapy (all p < 0.001). Lack of receipt of chemotherapy was associated with decreased overall survival (HR 1.33, 95% CI 1.12-1.59, p = 0.001). A 38-county cluster in West Texas had lower receipt of chemotherapy (relative risk 0.88, p = 0.02) and increased breast cancer mortality (p = 0.03) compared to the rest of Texas. Older age, increased poverty and rural geographical location are barriers to the receipt of chemotherapy. Interventions that target these barriers may reduce health disparities and improve breast cancer survival.

Identifiants

pubmed: 30868330
doi: 10.1007/s10552-019-01151-9
pii: 10.1007/s10552-019-01151-9
pmc: PMC7239038
mid: NIHMS1582322
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-415

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States

Références

Breast Cancer Res Treat. 2018 Jan;167(1):1-8
pubmed: 28884392
J Clin Oncol. 2012 Sep 1;30(25):3058-64
pubmed: 22869890
J Clin Oncol. 2014 Sep 1;32(25):2758-64
pubmed: 25071111
Arch Intern Med. 2006 Nov 13;166(20):2244-52
pubmed: 17101943
Int J Health Geogr. 2005 May 18;4:11
pubmed: 15904524
Aust J Rural Health. 2012 Oct;20(5):259-64
pubmed: 22998200
J Clin Oncol. 2015 Oct 1;33(28):3177-85
pubmed: 26304878
J Environ Public Health. 2012;2012:959343
pubmed: 22518193
J Clin Oncol. 2015 Jul 20;33(21):2337-44
pubmed: 25940726
J Oncol Pract. 2017 Apr;13(4):e353-e394
pubmed: 28326862
Eur J Cancer Care (Engl). 2016 Jan;25(1):93-8
pubmed: 25871852
Cancer. 2009 Jul 1;115(13):2999-3008
pubmed: 19452539
Breast Cancer Res Treat. 2013 Jan;137(1):247-60
pubmed: 23139057
J Clin Oncol. 2005 Sep 20;23(27):6639-46
pubmed: 16170171
N C Med J. 2014 Jul-Aug;75(4):239-46
pubmed: 25046086
Cancer. 2008 Jan 1;112(1):171-80
pubmed: 18040998

Auteurs

Parijatham S Thomas (PS)

Department of Clinical Cancer Prevention, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA. psthomas@mdanderson.org.

Caleb A Class (CA)

Department of Biostatistics, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA.

Tanmay R Gandhi (TR)

Department of Biostatistics, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA.

Arvind Bambhroliya (A)

Department of Neurology, The University of Texas Health Sciences Center at Houston, Houston, TX, USA.

Kim-Anh Do (KA)

Department of Biostatistics, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA.

Abenaa M Brewster (AM)

Department of Clinical Cancer Prevention, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA.
Department of Epidemiology, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH